Ngā hua rapu - Mary MacPartlin

  • E whakaatu ana i te 1 - 4 hua o te 4
Whakamahine hua
  1. 1
    A β-catenin/TCF-coordinated chromatin loop at <i>MYC</i> integrates 5′ and 3′ Wnt responsive enhancers

    A β-catenin/TCF-coordinated chromatin loop at <i>MYC</i> integrates 5′ and 3′ Wnt responsive enhancers mā Gregory S. Yochum, Colette M. Sherrick, Mary MacPartlin, Richard H. Goodman

    I whakaputaina 2009
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    The ABL Switch Control Inhibitor DCC-2036 Is Active against the Chronic Myeloid Leukemia Mutant BCR-ABLT315I and Exhibits a Narrow Resistance Profile

    The ABL Switch Control Inhibitor DCC-2036 Is Active against the Chronic Myeloid Leukemia Mutant BCR-ABLT315I and Exhibits a Narrow Resistance Profile mā Christopher A. Eide, Lauren T. Adrian, Jeffrey W. Tyner, Mary Mac Partlin, David J. Anderson, Scott Wise, Bryan D. Smith, Peter A. Petillo, Daniel L. Flynn, Michael W. Deininger, Thomas O’Hare, Brian J. Druker

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Kinase Domain Mutants of Bcr-Abl Exhibit Altered Transformation Potency, Kinase Activity, and Substrate Utilization, Irrespective of Sensitivity to Imatinib

    Kinase Domain Mutants of Bcr-Abl Exhibit Altered Transformation Potency, Kinase Activity, and Substrate Utilization, Irrespective of Sensitivity to Imatinib mā Ian J. Griswold, Mary MacPartlin, Thomas G.P. Bumm, Valerie L. Goss, Thomas O’Hare, Kimberly A. Lee, Amie S. Corbin, Eric P. Stoffregen, Caitlyn Smith, Kara Johnson, Erika M. Mosesón, Lisa J. Wood, Roberto D. Polakiewicz, Brian J. Druker, Michael W. Deininger

    I whakaputaina 2006
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    A gene expression signature of CD34+ cells to predict major cytogenetic response in chronic-phase chronic myeloid leukemia patients treated with imatinib

    A gene expression signature of CD34+ cells to predict major cytogenetic response in chronic-phase chronic myeloid leukemia patients treated with imatinib mā Shannon K. McWeeney, Lucy Pemberton, Marc Loriaux, Kristina Vartanian, Stephanie G. Willis, Gregory S. Yochum, Beth Wilmot, Yaron Turpaz, Raji Pillai, Brian J. Druker, Jennifer L. Snead, Mary MacPartlin, Stephen G. O’Brien, Junia V. Melo, Thoralf Lange, Christina A. Harrington, Michael W. Deininger

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: